Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA
Today, Terumo Blood and Cell Technologies have announced US Food and Drug Administration (FDA) clearance […]
Alterity Therapeutics Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial
Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today […]
Jasper Therapeutics Announces Positive Follow-up Clinical Data from Investigator-Sponsored Study of Briquilimab Conditioning in Sickle Cell Disease Patients
Jasper Therapeutics, a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to […]
Global Sarcoma Therapy Now Approved For New Zealand Patients
Independent biopharmaceutical company, Specialised Therapeutics (ST), is pleased to announce that its portfolio therapy to […]
Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis
Chiesi Global Rare Diseases announced today that the US Food and Drug Administration (FDA) has […]
Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines
Aera Therapeutics announced its launch today with a vision to harness its proprietary delivery platform […]
ARX517 Shows Encouraging Single-Agent Safety and Efficacy Data in Patients with Advanced Prostate Cancer
Ambrx Biopharma today announced encouraging initial data from its ongoing Phase 1 trial investigating ARX517, […]
Aqilion announces Pre-clinical Licensing and Strategic Research Collaboration Agreement with Merck
Aqilion today announced an exclusive license and strategic research collaboration with Merck to discover, develop […]
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership
LIfT BioSciences, a pioneering pre-clinical stage company moving into first-in-human trials with an allogeneic neutrophil […]
Previa Medical Raises €2.1 Million for AI Solution to Prevent Sepsis
Previa Medical, a deeptech start-up specialized in developing predictive medical devices for alerting healthcare providers […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more